Navigating Your Journey: What is the Average Maintenance Dose of Mounjaro for Sustainable Weight Loss?

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide (Mounjaro) has transformed weight management by targeting two hormone pathways simultaneously: GLP-1 and GIP receptors. Clinical trials show that patients maintaining doses of 10–15 mg per week achieve significant, durable weight loss while managing side effects effectively. Understanding your personal maintenance dose is key to long-term success.

Understanding Tirzepatide Maintenance Dosing for Lasting Results

Tirzepatide operates differently than single-hormone GLP-1 medications. By activating both GLP-1 and GIP receptors, it produces stronger appetite suppression and metabolic effects at lower doses. Most patients find their maintenance range—the dose that balances weight loss with tolerability—somewhere between 10 and 15 mg administered once per week. This range typically emerges after a gradual 16–20 week titration schedule starting at 2.5 mg.

The maintenance dose is not a one-size-fits-all number. Your body composition, metabolic rate, existing health conditions, and genetic factors all influence the dose your body needs. Some individuals sustain excellent results at 10 mg, while others require 15 mg for optimal appetite control and glucose regulation. The goal is finding the lowest effective dose that delivers results you can maintain long-term without excessive side effects.

Clinical Evidence Behind Common Maintenance Dose Ranges

The SURMOUNT clinical trials, which evaluated tirzepatide for weight management, demonstrated that participants using 15 mg doses achieved an average weight reduction of 22% body weight over 72 weeks. Notably, the difference in weight loss between 10 mg and 15 mg doses was modest—approximately 2–3% body weight—suggesting that many individuals hit a strong efficacy plateau at the 10 mg maintenance level. Patients who discontinued the medication regained weight progressively, highlighting that maintenance dosing requires consistent, long-term use.

Real-world data from clinical practices shows that approximately 60–70% of patients stabilize at 10 mg maintenance, while 25–35% require 15 mg for sustained results. Doses above 15 mg are reserved for specific clinical circumstances and are not considered standard maintenance therapy. Regular monitoring of weight, appetite, and gastrointestinal tolerance helps determine whether your current dose remains optimal or needs adjustment.

Factors That Determine Your Personal Maintenance Threshold

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Beyond genetics, your starting weight, age, and presence of type 2 diabetes affect maintenance dosing. Patients with existing diabetes may need slightly higher doses to achieve optimal glucose control alongside weight loss. Liver and kidney function also matter—individuals with reduced kidney or liver capacity may require dose adjustments or careful monitoring. A personalized approach that considers all these variables produces better long-term outcomes than guessing.

Accessing Tirzepatide at Your Optimal Dose Without Price Surprises

PlexusDx compounds tirzepatide injections starting at $289/mo (or $249/mo on the 6-month plan), and crucially, your monthly cost remains flat regardless of which dose your body needs. Whether your maintenance settles at 10 mg, 12.5 mg, or 15 mg per week, the price stays the same—a model built on the principle that your dose may need to go up, but your price won't. This transparency removes the financial anxiety from dose titration and allows you and your provider to focus purely on clinical outcomes.

PlexusDx medications come from licensed 503A compounding pharmacies and are available in all 50 states without insurance requirements or membership fees. Tirzepatide injections qualify for HSA and FSA accounts, lowering your actual out-of-pocket cost further. After your first month of treatment, you can add the Precision Peptide Genetic Test for $99 to refine your personalized therapy plan based on your unique metabolic genetics.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical maintenance dose of tirzepatide for weight loss?

Most patients achieve sustainable weight loss maintenance on tirzepatide doses of 10–15 mg per week. Approximately 60–70% stabilize at 10 mg, while 25–35% require 15 mg for optimal results. Your personal maintenance dose depends on your genetics, starting weight, and response pattern.

How much weight loss can I expect to maintain on a standard maintenance dose?

Clinical trials show that patients on 15 mg tirzepatide maintained approximately 20–22% body weight reduction over one year. Those on 10 mg typically achieved 18–20% reductions. Maintenance requires continuous use; weight regain occurs if the medication is discontinued.

Does my tirzepatide cost change if my dose increases during titration?

No. PlexusDx charges a flat $289 per month for compounded tirzepatide injections regardless of your dose. Your price remains constant as your dose may increase—a transparent pricing model designed to support your personalized therapy journey.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded tirzepatide from PlexusDx as effective as brand-name Mounjaro?

PlexusDx compounds tirzepatide from licensed 503A pharmacies using the same active pharmaceutical ingredient as Mounjaro. Efficacy depends on proper manufacturing standards, storage, and dosing—all of which PlexusDx maintains. Individual results vary based on genetics, adherence, and lifestyle factors.

Related Reading

• Average Weight Loss On Ozempic
• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.